Organogenesis Holdings Inc. Announces Management Change
24 août 2020 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Reports Second Quarter and First Half 2020 Financial Results
10 août 2020 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Latest Advanced Wound Care Innovations and Research from Organogenesis to be Highlighted at SAWC Spring | WHS 2020 Virtual Meeting
23 juil. 2020 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
Organogenesis Holdings Inc. Reports Preliminary Revenue Results for Second Quarter 2020
15 juil. 2020 07h30 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., July 15, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2020 Financial Results on August 10, 2020
29 juin 2020 07h30 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., June 29, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Holdings Inc. Reports First Quarter 2020 Financial Results
11 mai 2020 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of...
Organogenesis Announces Virtual Education Events for April
13 avr. 2020 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., April 13, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of...
Organogenesis Holdings Inc. Reports Preliminary Revenue Results for First Quarter 2020
08 avr. 2020 16h05 HE
|
Organogenesis Holdings Inc.
Withdraws Fiscal Year 2020 Revenue GuidanceAnnounces May 11, 2020 Earnings Conference Call CANTON, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading...
Organogenesis To Sponsor March 26 Webinar, “Taking Control of the Wound Healing Environment,” Featuring Dr. Alisha Oropallo
25 mars 2020 09h15 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., March 25, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...
Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2019 Financial Results; Introduces Fiscal Year 2020 Revenue Guidance
09 mars 2020 16h05 HE
|
Organogenesis Holdings Inc.
CANTON, Mass., March 09, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization...